Skip to main content

Home/ Diseases/ Group items tagged trial

Rss Feed Group items tagged

Matti Narkia

Vitamin D and MS: Burton - 1 views

  •  
    "Dr. Jodie Burton is the acting principal investigator (PI) of the dose-escalation trial of oral vitamin D3 with calcium supplementation in patients with multiple sclerosis with Dr. O'Connor. She started the trial as his fellow, while doing an additional 2 years of training in MS specifically after she received her neurology certification. She completed her fellowship training in 2007. Now she is staff doing clinical research and continuing with the vitamin D trial. As of August 2009, she will be Assistant Professor in Neurology in the Department of Clinical Neuroscience in Calgary and at the University of Calgary. She will be part of the MS team there with Dr. Luanne Metz and the MS group. Please scroll down for an abstract of the trial: A Phase I/II dose-escalation trial of oral vitamin D3 with calcium supplementation in patients with multiple sclerosis." Conclusions: High-dose VD3 (~10 000 IU/day, possibly higher) in MS is safe and tolerable, with evidence of clinical improvement.
Matti Narkia

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocar... - 0 views

  •  
    Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.\nLancet. 1999 Aug 7;354(9177):447-55. Erratum in: Lancet 2001 Feb 24;357(9256):642. Lancet. 2007 Jan 13;369(9556):106.\nPMID: 10465168
Matti Narkia

Vitamin D and calcium supplementation reduces cancer risk: results of a randomized tria... - 0 views

  •  
    Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007 Jun;85(6):1586-91. PMID: 17556697 [PubMed - indexed for MEDLINE]
Matti Narkia

A meta-analytic review of double-blind, placebo-controlled trials of antidepressant eff... - 0 views

  •  
    Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007 Jul;68(7):1056-61. PMID: 17685742 [PubMed - in process]
Matti Narkia

Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a ra... - 1 views

  •  
    Taubert D, Roesen R, Lehmann C, Jung N, Schomig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA. 2007 Jul 4;298(1):49-60. PMID: 17609490 [PubMed - indexed for MEDLINE]
Matti Narkia

Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary h... - 0 views

  •  
    Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: A meta-analysis of randomized controlled trials.\nZhao YT, Chen Q, Sun YX, Li XB, Zhang P, Xu Y, Guo JH.\nAnn Med. 2009 Jan 16:1-10. [Epub ahead of print]\nPMID: 19148838
Matti Narkia

Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck: A Phase 2 Tr... - 0 views

  •  
    Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial. Barrera JL, Verastegui E, Meneses A, Zinser J, de la Garza J, Hadden JW. Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):345-51. PMID: 10722007
Christine Redmond

Will New Weight-loss Drug Make it to Market? - 0 views

  •  
    Lorcaserin is one of the most advanced antiobesity drugs in clinical development; two others include Qnexa and Contrave. With late-stage trials having reported results for each of these drugs this year, many analysts are sceptical that lorcaserin will be approved by authorities, as major trial results indicate this drug may only just meet the FDA criterion for weight management.
Matti Narkia

Hyperbaric treatment effective for autism - UPI.com - 0 views

  •  
    MELBOURNE, Fla., March 12 (UPI) -- A U.S. controlled trial of hyperbaric treatments for children with autism has determined such treatments can improve the patients' conditions.
Matti Narkia

Comprehensive Cancer Information - National Cancer Institute - cancer.gov - 0 views

  •  
    The National Cancer Institute's research programs are extensive and contain many innovative initiatives. I invite you to explore our Web site to find out more about the exciting work being conducted here at NCI and by NCI-supported scientists throughout the country. You will also find valuable cancer-related information of all kinds. For the general public, patients, and health professionals, we offer consumer-oriented information on a wide range of topics as well as comprehensive descriptions of our research programs and clinical trials. Scientists will find detailed information on specific areas of research interest and funding opportunities.
Matti Narkia

Experimental Drug May Work In Many Cancers - 0 views

  •  
    "SCIENTISTS have shown that a new class of cancer drugs called PARP inhibitors, currently being tested in clinical trials to treat breast and ovarian cancer could have dramatic results when used to treat other solid tumours, according to work presented at the NCRI Cancer Conference today. "
AMVital Nutrition

Turmeric for Thyroid: Uses, Safety & Dosage - AMVital - 0 views

  •  
    If you like the concept of using food as medicine, you may name it food pharmacology. Medicines are an evident example of how microscopic compounds can remarkably change the human body. However, what's even more mesmerizing is the profound effect foods, and natural herbs can have on the body. But how can we incorporate food's healing properties into our everyday lives? "Pharmacognosy" is used to study medicines derived from natural bases. Due to its healing effects, turmeric curcumin has welcomed much attentiveness in research and wellness communities over the years. To date, 230 clinical trials have been performed to discover its many health benefits! A quick search of "curcumin" in PubMed induces nearly 18,000 results. Turmeric can help those with autoimmunity and the thyroid, reduces whole-body inflammation, heals the gut, and detoxify heavy metals from the body.
Matti Narkia

Pomegranate juice consumption for 3 years by patients with carotid artery stenosis redu... - 0 views

  •  
    Aviram M, Rosenblat M, Gaitini D, Nitecki S, Hoffman A, Dornfeld L, Volkova N, Presser D, Attias J, Liker H, Hayek T. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood p
Matti Narkia

Cancer Resources from OncoLink | Treatment, Research, Coping, Clinical Trials, Prevention - 0 views

  •  
    OncoLink was founded in 1994 by Penn cancer specialists with a mission to help cancer patients, families, health care professionals and the general public get accurate cancer-related information at no charge. Recent changes have been made to OncoLink to update the look and feel of our site. OncoLink is designed to make it easy for the general public to navigate through the pages to obtain the information that they want. The home page has buttons and hypertext links. If you click on the buttons or the underlined text with your mouse, you will go directly to your area of interest.
Matti Narkia

The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of In... - 0 views

  •  
    Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007 Apr;30(4):980-6. Epub 2007 Feb 2. PMID: 17277040 [PubMed - in
Matti Narkia

A higher dose of vitamin d reduces the risk of falls in nursing home residents: a rando... - 0 views

  •  
    Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. \nA higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study.\nJ Am Geriatr Soc. 2007 Feb;55(2):234-9.\nPMID: 17302660 [PubMed -
Christine Redmond

New Hope on the Horizon for Obesity - 0 views

  •  
    Current drug options for obesity are limited; however, two new weightloss drugs - Contrave and Qnexa - have recently reported positive results in late-stage trials. Availability is expected soon
Christine Redmond

Isentress Durability for Drug-Naïve HIV patients - 0 views

  •  
    Isentress is a new HIV treatment in development. Recent studies have shown Isentress-based therapy maintains activity at 96 weeks in treatment-naïve HIV patients, comparable to efavirenz, which is a current favourite for this patient pool. The benefits of Isentress-based therapy, however, are improved side effect and lipid profiles.
croservices

Tech-Enabled Contract Research Organization | Vial CRO - 1 views

  •  
    Vial is a technology enabled Contract Research Organization (CRO) that delivers faster, higher quality trial outcomes.
1 - 20 of 21 Next ›
Showing 20 items per page